AssetMark’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
AssetMark's NEO Position: Q3 2026 in Review
AssetMark increased its NeoGenomics (NEO) stake by 45% in Q3 2026, buying an estimated $19.7K and bringing the position to 3,841 shares worth $70.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1759.
AssetMark first reported a position in NEO in Q2 2025 and has held it in 6 quarters since. 235 funds tracked by Wall St. Rank hold NEO as of Q3 2026.
- AssetMark held 3,841 shares of NeoGenomics worth $70.5K as of Q3 2026.
- AssetMark bought 1,191 NeoGenomics shares in Q3 2026, an estimated $19.7K.
- NeoGenomics made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1759 holding.
- AssetMark first reported a position in NeoGenomics in Q2 2025 and has held it in 6 quarters since.
- 235 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.